TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer

Anita Langerød¹ , Hongjuan Zhao^2,3 , Ørnulf Borgan⁴ , Jahn M Nesland^5,6 , Ida RK Bukholm⁷ , Tone Ikdahl⁸ , Rolf Kåresen^6,9 , Anne-Lise Børresen-Dale^1,6 and Stefanie S Jeffrey²

¹  Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway N-0310

²  Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA

³  Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA

⁴  Department of Mathematics, University of Oslo, Oslo, Norway N-0316

⁵  Department of Pathology, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway N-0310

⁶  Faculty of Medicine, University of Oslo, Oslo, Norway

⁷  Department of Surgery, Akershus University Hospital, Nordbyhagen, Norway N-1474

⁸  Cancer Center, Ullevål University Hospital, Oslo, Norway N-0407

⁹  Department of Surgery, Ullevål University Hospital, Oslo, Norway N-0407